Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 18, Number 3—March 2012

Research

Chicken as Reservoir for Extraintestinal Pathogenic Escherichia coli in Humans, Canada

Catherine Racicot Bergeron1, Catharine Prussing1, Patrick Boerlin, Danielle Daignault, Lucie Dutil2, Richard J. Reid-Smith, George G. Zhanel, and Amee R. MangesComments to Author 
Author affiliations: McGill University, Montréal, Québec, Canada (C. Racicot Bergeron, C. Prussing, A.R. Manges); University of Guelph, Guelph, Ontario, Canada (P. Boerlin, R.J. Reid-Smith); Public Health Agency of Canada, Saint-Hyacinthe, Québec, Canada (D. Daignault, L. Dutil); Public Health Agency of Canada, Guelph (R.J. Reid-Smith); University of Manitoba, Winnipeg, Manitoba, Canada (G.G. Zhanel)

Suggested citation for this article

Abstract

We previously described how retail meat, particularly chicken, might be a reservoir for extraintestinal pathogenic Escherichia coli (ExPEC) causing urinary tract infections (UTIs) in humans. To rule out retail beef and pork as potential reservoirs, we tested 320 additional E. coli isolates from these meats. Isolates from beef and pork were significantly less likely than those from chicken to be genetically related to isolates from humans with UTIs. We then tested whether the reservoir for ExPEC in humans could be food animals themselves by comparing geographically and temporally matched E. coli isolates from 475 humans with UTIs and from cecal contents of 349 slaughtered animals. We found genetic similarities between E. coli from animals in abattoirs, principally chickens, and ExPEC causing UTIs in humans. ExPEC transmission from food animals could be responsible for human infections, and chickens are the most probable reservoir.

Extraintestinal pathogenic Escherichia coli (ExPEC) is the leading cause of community-acquired urinary tract infections (UTIs) in humans, accounting for >85% of UTIs (1). Each year, 6–8 million UTIs are diagnosed in the United States, and 130–175 million are diagnosed worldwide. Estimated direct health care costs related to uncomplicated UTIs in the United States are $1–$2 billion per year (1,2). UTIs also can lead to more severe illnesses, such as pyelonephritis, bacteremia, and sepsis (3). During the past decade, the emergence of drug-resistant E. coli has dramatically increased. As a consequence, the management of UTIs, which was previously straightforward, has become more complicated; the risks for treatment failure are higher, and the cost of UTI treatment is increasing (4).

In the past, extraintestinal E. coli infections have been described as sporadic infections caused by bacteria that originate from the host’s intestinal tract. However, ExPEC strains recently have been associated with possible outbreaks (5). Communitywide outbreaks have been described in south London (E. coli O15:K152:H1) (6); Copenhagen (E. coli O78:H10) (7); Calgary, Alberta, Canada (extended-spectrum β-lactamase–producing E. coli) (8); and California, USA (trimethoprim/sulfamethoxazole–resistant E. coli) (9). These outbreaks suggest that ExPEC can be spread to the intestinal tracts of persons in the community by a common source or vehicle.

We recently described the results of a study that characterized the genetic similarities between E. coli isolates recovered from retail meat, particularly chicken, and ExPEC in humans causing community-acquired UTIs (10). That study oversampled isolates from retail chicken because evidence suggested that chicken was likely to be the primary reservoir of ExPEC in humans (1116). To exclude the possibility that isolates from other retail meat sources (beef and pork) might also be genetically related to UTI isolates from humans, we first aimed to characterize additional E. coli isolates recovered from retail beef and pork sources. These new isolates from retail meat were added to the preexisting collection of retail meat isolates and compared with the same UTI isolates from humans. Second, we aimed to determine whether transmission was primarily human to human through food or whether an animal source was involved. In the case of human-to-human transmission through food, E. coli strains from humans would be introduced during the meat preparation process by food handlers. In the case of an animal source, the E. coli would derive from the cecal content of the animal itself, and contamination would occur during the slaughtering process. On the basis of previous findings, we hypothesized that a food animal reservoir exits for ExPEC that cause UTIs in humans and that chicken is the primary source. To evaluate this hypothesis, we analyzed isolates from animals entering the food chain. E. coli isolates recovered from the cecal contents of slaughtered food animals (beef cattle, chickens, and pigs) were compared with the preexisting geographically and temporally matched collection of isolates from humans with UTIs.

Methods

Study Design

A total of 1,561 geographically and temporally matched E. coli isolates from animals and from humans with UTIs were used for the different comparisons (Table 1).The study target area was primarily the province of Québec, Canada; however, other regions were included as described below. The study period was 2005–2007. The McGill University Institutional Review Board approved the study protocol (A01-M04-05A).

Sampling of E. coli Isolates from Humans with UTI, Montreal, Québec

The 351 E. coli isolates recovered from humans with UTIs were collected in Montréal during June 2005–May 2007 (17). Women 18–45 years of age who had a suspected UTI were recruited at the McGill University Student Health Services and the Centre Local de Services Communautaires Métro Guy. UTI was defined as >2 symptoms or signs, including dysuria, increased urinary frequency or urgency, pyuria, hematuria, and >102 CFU of E. coli per mL of clean-catch urine (18). Specimen culture and bacterial identification have been described (17). One random isolate from each urine sample was selected. In case of UTI recurrence, only the isolate from the first UTI episode was included. The collection was assembled as follows. A random set of 116 fully susceptible isolates was selected. A random set of 170 isolates resistant to >1 antimicrobial agents was assembled; in addition, specific groups of antimicrobial-resistant E. coli were included. These E. coli strains have been closely associated with possible outbreaks of extraintestinal infections (69,1921). In particular, cephalosporin-resistant E. coli frequently has been observed in UTI outbreaks and in poultry products (8,13,16,1921). Hence, all 19 cephalothin-resistant E. coli isolates were included. We included 46 representative members of E. coli clonal groups that were known to cause clusters of UTI among unrelated women on the basis of the hypothesis that they would be more likely to be related to food sources. This collection of 351 UTI-associated E. coli isolates is referred to as the Manges collection.

Sampling of E. coli Isolates from Humans with UTIs, Canada

We added 124 isolates from humans from sources across Canada to increase the diversity of the collection of E. coli isolates causing UTIs beyond those in Québec alone. These samples were collected from patients with community- and hospital-acquired UTIs during 2007–2008. This collection, provided by 1 of the authors (G.G.Z.), is referred to as the Zhanel collection.

Sampling of E. coli from Retail Meat

We systematically selected and evaluated additional isolates from retail beef and pork. The retail meat collection totaled 737 isolates from beef (242), chicken (253), and pork (242) (10). These isolates were collected in Montréal, areas of Québec outside Montréal, parts of Ontario, and other areas of Canada during 2005–2007. All of these isolates originated from the collection of the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS). Because antimicrobial resistance has been associated with ExPEC clonal groups and outbreaks of UTIs (69,17,22), we oversampled antimicrobial-resistant isolates from retail meat; 60% of sampled isolates were resistant to >1 antimicrobial drugs, and 40% were fully susceptible. However, resistance in retail beef was fairly low; therefore the proportion of resistant E. coli from retail beef was only 48%.

Sampling of E. coli from Food Animals in Abattoirs

From the CIPARS collection, we selected 349 E. coli isolates from animals in abattoirs. These bacteria were isolated from the cecal contents of slaughtered food animals (23). Because the primary hypothesis concerned a chicken reservoir and we already had demonstrated that isolates from humans are less likely to be related to isolates from beef and pork, we included isolates in the following proportions: 20% beef cattle, 60% chickens, and 20% pigs. We chose 299 isolates from 2005–2007 as follows. Isolates from chickens were selected from abattoirs in Québec and Ontario because there are poultry abattoirs operating in Québec and Ontario and because E. coli from humans with UTIs was recovered primarily from women in Québec. In contrast, beef cattle and pig abattoirs are fewer and are located across Canada. Therefore, isolates were selected on the basis of the annual slaughter volume rather than on location. Sampling was conducted in proportion to the susceptibility levels for each animal species within the whole CIPARS collection. However, we included all 5 nalidixic acid–resistant isolates because this agent can be used as an indicator of resistance to fluoroquinolones (24).

Furthermore, because the study focused on chicken, we included a random sample of 50 additional isolates from chickens in abattoirs in other Canadian provinces. They were also selected from the CIPARS collection during the same period (2005–2007).

Antimicrobial Susceptibility Testing

We performed antimicrobial susceptibility testing on all E. coli isolates, except those from the Zhanel collection. Antimicrobial susceptibility screening using a panel of 15 agents (amikacin, amoxicillin/clavulanic acid, ampicillin, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole, tetracycline, and trimethoprim/sulfamethoxazole) was conducted by the Public Health Agency of Canada, Laboratory for Foodborne Zoonoses. The protocol of the broth microdilution method used was fully described in the 2007 CIPARS report (23). Intermediate resistance for all isolates was classified as susceptible. The antimicrobial resistance patterns are provided for informational purposes only because isolates were sampled in part according to their antimicrobial resistance phenotype. Thus, the patterns observed do not reflect the prevalence of antimicrobial resistance for any of the sources.

Clonal Group Definition and Typing

Isolates were typed by multilocus variable number tandem repeat analysis (MLVA) (25) and enterobacterial repetitive intergenic consensus sequence 2 (ERIC2) PCR fingerprinting (26) in our laboratory and the McGill University and Genome Québec Innovation Center as described. A clonal group was defined as >2 E. coli isolates from human and animal sources that shared the same MLVA profile and ERIC2 PCR fingerprint. All clonal group members were further typed by phylotyping and multilocus sequence typing (MLST). Then, according to the results obtained, related isolates were selected for O:H serotyping and pulsed-field gel electrophoresis (PFGE).

Phylotyping (27) and MLST (28) (http://mlst.ucc.ie/mlst/dbs/Ecoli) were performed in our laboratory and in the McGill University and Genome Québec Innovation Center as described. Allelic profile and sequence type (ST) were assigned according to the scheme at this website. O (somatic) and H (flagellar) antigens were serotyped for clonal group isolates that shared the same phylogenetic group and MLST profile; serotyping was performed by the Public Health Agency of Canada, Laboratory for Foodborne Zoonoses, according to established protocols. Isolates that did not react with O antiserum were classified as nontypeable. PFGE of XbaI-digested DNA was conducted in our laboratory by using the protocol for molecular subtyping of E. coli O157:H7 developed by the Centers for Disease Control and Prevention (29). Clonal group members that exhibited the same phylotype and MLST profile were tested. Gel fingerprints were visually compared, and strain relatedness was classified according to the Tenover criteria (30).

Statistical Analyses

Differences in proportions were assessed by use of the χ2 test. Statistical significance was defined as a p value <0.05. All analyses were conducted using Stata version 9.0 (StataCorp LP, College Station, TX, USA).

Results

Isolates from Retail Meat

We identified 15 clonal groups, comprising 63 isolates. The 15 groups contained 22 isolates from humans with UTIs and 41 isolates from retail meat. Of the 41 isolates from retail meat, 6 (15%) were from retail beef, 29 (71%) from retail chicken, and 6 (15%) from retail pork. Considering the sampling proportions (66% beef and pork [484/737] and 34% chicken [253/737]), the fraction of isolates from beef and pork related to isolates from humans with UTIs was significantly lower than expected on the basis of the sampling fraction (29% observed vs. 66% expected; p<0.001, χ2 test). Isolates from chicken were represented in greater numbers among clonal groups. All clonal group members had the same phylotype. According to MLST, 2 of these clonal groups (groups 1 and 3) contained isolates from newly sampled retail beef and pork (EC01DT07-0827-01 and EC01DT06-1559-01) and isolates from humans with UTIs that shared the same STs. These isolates were further typed (Table 2): XbaI PFGE patterns differed by >7 bands within the clonal groups associated with retail meat.

Isolates Collected from Abattoirs

We identified 8 clonal groups containing 46 isolates from humans and from food animals at abattoirs. These clonal groups comprised 17 isolates from humans with UTIs and 29 from abattoir animals (1 [3%] beef cattle, 23 [79%] chickens, 5 [17%] pigs). The proportion of chicken was higher than expected with 79% observed versus 60% expected, in accordance with the 60% sampling fraction (p = 0.034, χ2 test). The 3 clonal groups including isolates that were further characterized, and thus more closely related, are described below (Table 2). According to the Tenover criteria (30), PFGE patterns of all animal strains differed from those of the human strains.

Abattoir clonal group 1 contained 11 isolates (2 from humans, 8 from chickens, 1 from a pig). All belonged to the same phylogenetic group (D) and showed the same sequence type (ST117). Two isolates from chickens (EC01AB07-0105-01 and EC01AB07-0425-01) had the same serotype (O180:H4), and the rest of the isolates had unique serotypes.

Abattoir clonal group 2 included 6 isolates (3 from humans, 1 from a chicken, 2 from pigs). They all belonged to phylogenetic group A but showed 4 different MLST profiles. Among them, ST746 was shared by 3 isolates (1 each from a human, chicken, and pig). However, they did not show the same O:H serotype.

Abattoir clonal group 3 contained 13 isolates (5 from humans, 6 from chickens, 2 from pigs), which all belonged to phylogenetic group A. The MLST profile ST10 was shared by 7 isolates (4 from humans, 3 from chickens). The 6 other isolates displayed different MLST profiles. Among the isolates exhibiting ST10, 3 from chickens (EC01AB05-0765-01, EC01AB07-0005-01, and EC01AB07-1330-01) showed the same serotype (O16:H48).

Discussion

Our first goal was to exclude retail beef and pork as a probable food source of E. coli causing UTIs. Our previous study (10), in which the sampling proportions for beef, chicken, and pork were not the same, clonal groups identified included 17% isolates from beef and pork and 83% from chicken (p = 0.03). In the current investigation, where the sampling proportions from retail meat were the same, 12 (29%) of isolates belonging to clonal groups were from beef and pork and 29 (71%) were isolated from chicken (p<0.001). Retail beef and pork isolates are much less likely than retail chicken isolates to be clonally related to isolates from humans with UTIs.

Our second goal was to determine whether the reservoir for ExPEC in humans causing community-acquired UTI was food animals, particularly chickens. The initial screening methods (MLVA and ERIC2) demonstrated that human samples and cecal samples from food animals in abattoirs can belong to the same clonal groups. Moreover, within certain abattoir clonal groups, isolates showed the same phylogenetic group and MLST sequence types, indicating that they may have originated from a recent common ancestor. The 3 major clonal groups with the highest level of similarity (groups 1, 2, and 3) included isolates from abattoir and retail meat (10), which suggests that food animals may serve as a reservoir for ExPEC in humans.

The 2 most common STs (ST10 and ST117), belonging to phylogenetic groups A and D, respectively, have already been reported from human and animal sources (11,3133). Although phylogenetic group A is typically associated with commensal E. coli (3), most human and animal isolates from the abattoir clonal groups belonged to this phylotype. Moreno et al. (34) and Ewers et al. (35) reported data suggesting that isolates from phylogenetic group A could be responsible for extraintestinal infections. Phylogenetic group D, which has frequently been associated with ExPEC in humans (3), was observed in 31% of the isolates from abattoir clonal groups. The lack of isolates from phylogenetic group B2 was unexpected because extraintestinal pathogenic strains often belong to this group (3). Studies from Jakobsen et al. have identified phylogroup B2 isolates from meat and animal sources, which demonstrates that B2 exists in the food animal reservoir (36,37). Our results may be explained by the fact that the isolates collected from abattoirs are more likely to be generic or commensal E. coli rather than typical ExPEC because they were collected from the cecal contents of healthy animals. The lack of phylogenetic group B2 isolates also could be explained by sampling variability or our selection method (based on MLVA and ERIC2 PCR genotyping first, followed by phylotyping). Phylogenetic group A and D were predominant among the isolates collected from abattoirs, which is consistent with results obtained by Jakobsen et al. (38) and Cortés et al. (11).

Although we oversampled isolates from abattoir chickens (60%), a significantly higher proportion of the isolates collected from abattoirs (79%; p = 0.034) included in the clonal groups were from chickens than from beef cattle or pigs; this proportion was higher than expected. This study confirms our hypothesis that chickens are a likely reservoir for ExPEC in humans. However, epidemiologic data, such as diet or other exposures, were not available for the humans with UTIs. This information could have been used to search for other potential routes of transmission (e.g., travel, water sources) and to strengthen the connection between poultry consumption and UTI.

We observed more heterogeneity in the PFGE results than in results from the other typing methods. PFGE is the standard for genotyping E. coli in the context of outbreaks, but it is generally not useful for establishing relationships between isolates from greater distances and over longer periods (12). MLST results may be a more relevant as housekeeping genes evolve more slowly and are more appropriate for examining questions related to global or regional epidemiology (39,40).

This study was strengthened by use of an ecologic design in which all isolates were systematically and purposively selected over the same period of time and geographic area (17,23), rather than sampling haphazardly by using existing clinical laboratory collections. The results suggest that potential ExPEC transmission from food animal sources is likely to be implicated in human infections and that chicken is a major reservoir. The possibility that ExPEC causing UTIs and other extraintestinal infections in humans could originate from a food animal reservoir raises public health concern. New interventions may be needed to reduce the level of food contamination and risk for transmission.

Ms Racicot Bergeron is a graduate student in the Department of Microbiology and Immunology at McGill University in Montréal, Québec. Her research interests include bacteriology and molecular epidemiology of ExPEC causing human diseases.

Acknowledgments

This manuscript is dedicated to Lucie Dutil, a wonderful person and outstanding colleague. Dr. Dutil died suddenly in August 2011 and is sadly missed by all who worked with her.

We thank members of the surveillance team of the Canadian Integrated Program for Antimicrobial Resistance Surveillance (Brent Avery and the Public Health Agency of Canada laboratory technicians).

This study was supported by the Public Health Agency of Canada (A.R.M); the Canadian Institutes of Health Research, Institute of Infection and Immunity; the Canadian Institutes of Health Research, MSc Award 3 (C.R.B.); and McGill University (C.R.B.).

References

  1. Zhang L, Foxman B. Molecular epidemiology of Escherichia coli mediated urinary tract infections. Front Biosci. 2003;8:e23544. DOIPubMed
  2. Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003;5:44956. DOIPubMed
  3. Smith JL, Fratamico PM, Gunther NW. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis. 2007;4:13463. DOIPubMed
  4. Pallett A, Hand K. Complicated urinary tract infections: practical solutions for the treatment of multiresistant gram-negative bacteria. J Antimicrob Chemother. 2010;65(Suppl 3):iii2533. DOIPubMed
  5. George DB, Manges AR. A systematic review of outbreak and non-outbreak studies of extraintestinal pathogenic Escherichia coli causing community-acquired infections. Epidemiol Infect. 2010;138:167990. DOIPubMed
  6. Phillips I, Eykyn S, King A, Gransden WR, Rowe B, Frost JA, Epidemic multiresistant Escherichia coli infection in West Lambeth Health District. Lancet. 1988;331:103841. DOIPubMed
  7. Olesen B, Kolmos HJ, Orskov F, Orskov I. Cluster of multiresistant Escherichia coli O78:H10 in greater Copenhagen. Scand J Infect Dis. 1994;26:40610. DOIPubMed
  8. Pitout JD, Gregson DB, Church DL, Elsayed S, Laupland KB. Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region. J Clin Microbiol. 2005;43:28449. DOIPubMed
  9. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med. 2001;345:100713. DOIPubMed
  10. Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis. 2010;16:8895. DOIPubMed
  11. Cortés P, Blanc V, Mora A, Dahbi G, Blanco JE, Blanco M, Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl Environ Microbiol. 2010;76:2799805. DOIPubMed
  12. Johnson JR, Kuskowski MA, Menard M, Gajewski A, Xercavins M, Garau J. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J Infect Dis. 2006;194:718. DOIPubMed
  13. Johnson JR, Kuskowski MA, Smith K, O'Bryan TT, Tatini S. Antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in retail foods. J Infect Dis. 2005;191:10409. DOIPubMed
  14. Johnson JR, Sannes MR, Croy C, Johnston B, Clabots C, Kuskowski MA, Antimicrobial drug–resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002–2004. Emerg Infect Dis. 2007;13:83846. DOIPubMed
  15. Johnson JR, Delavari P, O'Bryan TT, Smith KE, Tatini S. Contamination of retail foods, particularly turkey, from community markets (Minnesota, 1999–2000) with antimicrobial-resistant and extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis. 2005;2:3849. DOIPubMed
  16. Schroeder CM, White DG, Ge B, Zhang Y, McDermott PF, Ayers S, Isolation of antimicrobial-resistant Escherichia coli from retail meats purchased in greater Washington, DC, USA. Int J Food Microbiol. 2003;85:197202. DOIPubMed
  17. Manges AR, Tabor H, Tellis P, Vincent C, Tellier PP. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis. 2008;14:157583. DOIPubMed
  18. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:55181. DOIPubMed
  19. Mendonça N, Leitao J, Manageiro V, Ferreira E, Canica M. Spread of extended-spectrum beta-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother. 2007;51:194655. DOIPubMed
  20. Lau SH, Reddy S, Cheesbrough J, Bolton FJ, Willshaw G, Cheasty T, Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol. 2008;46:107680. DOIPubMed
  21. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother. 2004;54:73543. DOIPubMed
  22. Woodford N, Kaufmann ME, Karisik E, Hartley JW. Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England. J Antimicrob Chemother. 2007;59:1069. DOIPubMed
  23. Government of Canada. Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2007. Guelph (Ontario): Public Health Agency of Canada; 2010.
  24. Ito CA, Gales AC, Tognim MC, Munerato P, Dalla Costa LM. Quinolone-resistant Escherichia coli. Braz J Infect Dis. 2008;12:59. DOIPubMed
  25. Manges AR, Tellis PA, Vincent C, Lifeso K, Geneau G, Reid-Smith RJ, Multi-locus variable number tandem repeat analysis for Escherichia coli causing extraintestinal infections. J Microbiol Methods. 2009;79:2113. DOIPubMed
  26. Johnson JR, O'Bryan TT. Improved repetitive-element PCR fingerprinting for resolving pathogenic and nonpathogenic phylogenetic groups within Escherichia coli. Clin Diagn Lab Immunol. 2000;7:26573.PubMed
  27. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:45558. DOIPubMed
  28. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol. 2006;60:113651. DOIPubMed
  29. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis. 2006;3:5967. DOIPubMed
  30. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:22339.PubMed
  31. Oteo J, Diestra K, Juan C, Bautista V, Novais A, Perez-Vazquez M, Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int J Antimicrob Agents. 2009;34:1736. DOIPubMed
  32. Valverde A, Canton R, Garcillan-Barcia MP, Novais A, Galan JC, Alvarado A, Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain. Antimicrob Agents Chemother. 2009;53:520412. DOIPubMed
  33. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol. 2008;46:39005. DOIPubMed
  34. Moreno E, Prats G, Planells I, Planes AM, Perez T, Andreu A. Characterization of Escherichia coli isolates derived from phylogenetic groups A and B1 causing extraintestinal infection [in Spanish]. Enferm Infecc Microbiol Clin. 2006;24:4839. DOIPubMed
  35. Ewers C, Li G, Wilking H, Kiessling S, Alt K, Antao EM, Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they? Int J Med Microbiol. 2007;297:16376. DOIPubMed
  36. Jakobsen L, Hammerum AM. Frimodt-MøllerN. Virulence of Escherichia coli B2 isolates from meat and animals in a murine model of ascending urinary tract infection (UTI): evidence that UTI is a zoonosis. J Clin Microbiol. 2010;48:297880. DOIPubMed
  37. Jakobsen L, Garneau P, Kurbasic A, Bruant G, Stegger M, Harel J, Microarray-based detection of extended virulence and antimicrobial resistance gene profiles in phylogroup B2 Escherichia coli of human, meat and animal origin. J Med Microbiol. 2011l;60:150211. DOIPubMed
  38. Jakobsen L, Kurbasic A, Skjøt-Rasmussen L, Ejrnaes K, Porsbo LJ, Pedersen K, Escherichia coli isolates from broiler chicken meat, broiler chickens, pork, and pigs share phylogroups and antimicrobial resistance with community-dwelling humans and patients with urinary tract infection. Foodborne Pathog Dis. 2010;7:53747. DOIPubMed
  39. Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol. 2005;295:383404. DOIPubMed
  40. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998;95:31405. DOIPubMed

Tables

Suggested citation for this article: Racicot Bergeron C, Prussing C, Boerlin P, Daignault D, Dutil L, Reid-Smith RJ, et al. Chicken as reservoir for extraintestinal pathogenic Escherichia coli in humans, Canada. Emerg Infect Dis [serial on the Internet] 2012 Mar [date cited]. http://dx.doi.org/10.3201/eid1803.111099

DOI: 10.3201/eid1803.111099

1These authors contributed equally to this article.

2Deceased.

Top of Page

Table of Contents – Volume 18, Number 3—March 2012

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Amee R Manges, Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 1020 Pine Ave West, 36B, Montréal, QC H3A 1A2, Canada





characters(s) remaining.

Comment submitted successfully, thank you for your feedback.

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

20th Anniversary - National Infant Immunization Week - Immunization. Power to Protect.

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO